¿ Amgen Inc., of Thousand Oaks, Calif., promoted Kathryn Falberg to senior vice president; Marc deBaridel to vice president, controller and chief accounting officer; and Kurt Gustafson to treasurer.
¿ AtheroGenics Inc., of Norcross, Ga., appointed Don Kirksey to vice president of business and corporate development.
¿ BioMira Inc., of Edmonton, Alberta, appointed Mark Young chief operating officer.
¿ CarboMed Inc., of Brentwood, Tenn., named John Watson president and CEO.
¿ Cellomics Inc., of Pittsburgh, named Alan Seadler vice president of operations, and Michael Nemzek senior vice president of sales and marketing.
¿ ChiRex Inc., of Stamford, Conn., named Frank Wright executive vice president, corporate development.
¿ Dendreon Corp., of Seattle, named Martin Simonetti chief financial officer.
¿ DepoMed Inc., of Foster City, Calif., appointed Bret Berner vice president, product development.
¿ Endocardial Solutions Inc., of Minneapolis, named Michael Dale vice president, worldwide sales.
¿ Genaissance Pharmaceuticals Inc., of New Haven, Conn., named to its board of directors Jurgen Drews, chairman of the board of International Biomedicine Management Partners Inc.; Stefan Ryser, CEO of International Biomedicine Management Partners Inc.; Henry Penner Jr., president and CEO of Neurogen Corp.; and Christopher Wright, head of the Global Private Equity business of Dresdner Kleinwort Benson.
¿ Human Genome Sciences Inc., of Rockville, Md., promoted Steven Ruben to vice president, research; Timothy Coleman to director, protein development; and Anders Brookes to director, intellectual property.